Maruzen Pharmaceuticals Co., Ltd.
Japanese maker of licorice, black ginger, perilla and oyster extracts for supplement and food brands.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
Maruzen Pharmaceuticals is a Japanese manufacturer of botanical and natural-product raw materials for the pharmaceutical, cosmetic, and food industries, headquartered in Onomichi, Hiroshima. The company is known for plant-derived extracts including licorice (glabridin), black ginger, perilla, pineapple, and oyster extracts, and operates its own production and quality-assurance functions across multiple factories (Headquarters Factory, Shin Onomichi, and Miyoshi). It supplies functional botanical ingredients on a B2B basis.
Certifications
1 of 1 certification independently confirmed. What this means
Capabilities
- PRODUCT TYPES
- Botanical Extracts · Licorice / Glabridin Extracts · Black Ginger Extracts · Perilla Extracts · Oyster Extracts · Food Additives
- CAPABILITIES
- Botanical extracts or ingredients · Custom development or formulation help · Lab testing or quality control
Sources
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Country-of-manufacture confirmed for the Hiroshima facility via FSSC 22000 certification; buyers should confirm country-of-origin per ingredient at quote stage
- Some marketed extracts span pharmaceutical, cosmetic, and food grades; confirm food/supplement-grade specification and documentation per order
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between Maruzen Pharmaceuticals Co., Ltd. and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Our Evaluation Method
A full assessment applies six checks. Source-Checked listings get a lighter review.
- Independent confirmation: Claims backed by documentation, not marketing copy
- How recent the data is: Information reviewed and dated within the last 12 months
- Sources we traced: Sources cited for every key claim
- Inconsistencies flagged: Where a company's claims and public records disagree, we say so
- What we disclose: Material connections stated directly on affected listings
- What we don't know: When we can't assess something, we say so explicitly
Interested in Maruzen Pharmaceuticals Co., Ltd.?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.